Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-29

FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Hydralazine Hydrochloride, marking an approved supplement to the product's existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

SUPPL AP for HYDRALAZINE HYDROCHLORIDE (HYDRALAZINE HYDROCHLORIDE)